3 Likes
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Intra-Cellular Therapies Announces FDA Acceptance of CAPLYTA® (lumateperone) sNDAs for the Treatment of Bipolar Depression | 0 | 197 | May 3, 2021 | |
| Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations | 0 | 279 | April 28, 2022 | |
| Intra-Cellular Therapies gets a boost on PhIII depression drug data | 0 | 179 | March 29, 2023 | |
| Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression in Adults | 5 | 332 | December 21, 2021 | |
| Intracellular Theraputics reports mixed results with Lumateperone in Bipolar | 0 | 272 | July 8, 2019 |